HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew T Roe Selected Research

Pathologic Constriction (Stenosis)

3/2016Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization.
1/2016Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry.
8/2008Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew T Roe Research Topics

Disease

124Acute Coronary Syndrome
01/2022 - 01/2002
97ST Elevation Myocardial Infarction
03/2021 - 09/2002
86Myocardial Infarction
11/2023 - 02/2002
83Hemorrhage
02/2024 - 12/2002
41Non-ST Elevated Myocardial Infarction
03/2021 - 01/2002
39Unstable Angina
01/2020 - 01/2002
36Stroke (Strokes)
11/2023 - 12/2002
33Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 11/2002
20Heart Failure
12/2020 - 03/2005
15Coronary Artery Disease (Coronary Atherosclerosis)
11/2023 - 09/2006
12Diabetes Mellitus
09/2023 - 05/2004
11Thrombosis (Thrombus)
01/2020 - 03/2005
10Chronic Renal Insufficiency
12/2018 - 03/2006
9Coronary Disease (Coronary Heart Disease)
01/2020 - 01/2002
9Infarction (Infarctions)
12/2018 - 12/2003
7Ischemic Stroke
01/2020 - 04/2016
7Cardiogenic Shock
02/2016 - 11/2005
6Chest Pain (Chest Pains)
12/2018 - 08/2002
6Myocardial Ischemia (Ischemic Heart Diseases)
01/2017 - 08/2002
6Shock
11/2013 - 06/2010
5Atrial Fibrillation
12/2019 - 11/2013
5Neoplasms (Cancer)
10/2019 - 07/2010
5Hypertension (High Blood Pressure)
06/2015 - 07/2006
4Ischemia
01/2020 - 02/2002
4Peripheral Arterial Disease
01/2020 - 01/2011
4Body Weight (Weight, Body)
08/2013 - 06/2009
3Gout
01/2020 - 05/2017
3Dyslipidemias (Dyslipidemia)
12/2019 - 01/2019
3Transient Ischemic Attack
10/2019 - 06/2015
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
10/2019 - 03/2014
3Heart Arrest (Cardiac Arrest)
01/2018 - 04/2014
3Pathologic Constriction (Stenosis)
03/2016 - 08/2008
3Renal Insufficiency (Renal Failure)
08/2014 - 09/2006
3Necrosis
07/2012 - 04/2005
2Prostatic Neoplasms (Prostate Cancer)
10/2021 - 03/2020

Drug/Important Bio-Agent (IBA)

49Clopidogrel (Plavix)FDA Link
01/2020 - 04/2006
34Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2024 - 01/2002
31Prasugrel HydrochlorideFDA Link
01/2020 - 01/2007
21Glycoproteins (Glycoprotein)IBA
03/2015 - 07/2003
18Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 07/2006
16alirocumabIBA
01/2021 - 11/2014
13TroponinIBA
01/2018 - 04/2005
12oxidized low density lipoproteinIBA
12/2020 - 09/2009
12Biomarkers (Surrogate Marker)IBA
01/2019 - 08/2002
12Platelet Membrane Glycoprotein IIbIBA
12/2010 - 09/2002
11LDL CholesterolIBA
12/2020 - 09/2009
10CreatinineIBA
01/2018 - 03/2009
10Heparin (Liquaemin)FDA LinkGeneric
06/2014 - 01/2002
92'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2020 - 11/2013
9Hemoglobins (Hemoglobin)IBA
04/2017 - 05/2008
9MB Form Creatine KinaseIBA
10/2014 - 12/2003
8Warfarin (Coumadin)FDA LinkGeneric
08/2014 - 02/2008
7omega-Chloroacetophenone (Mace)IBA
01/2022 - 01/2019
7Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2019 - 12/2003
7Enoxaparin (Lovenox)FDA LinkGeneric
03/2011 - 01/2002
7Eptifibatide (Integrilin)FDA Link
03/2008 - 12/2002
6TicagrelorIBA
01/2020 - 06/2011
6Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2017 - 10/2005
6Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
06/2014 - 12/2002
5pro-brain natriuretic peptide (1-76)IBA
10/2019 - 07/2012
5HDL CholesterolIBA
11/2018 - 10/2008
5LipidsIBA
09/2016 - 02/2005
5AnticoagulantsIBA
04/2016 - 03/2012
4Proprotein Convertase 9IBA
12/2020 - 11/2018
4Creatine Kinase (Creatine Phosphokinase)IBA
10/2014 - 01/2006
4ORALIT (ORS)IBA
05/2009 - 09/2006
4Platelet Membrane GlycoproteinsIBA
01/2005 - 12/2002
3apixabanIBA
01/2022 - 01/2016
3Thrombin Receptors (Thrombin Receptor)IBA
01/2022 - 01/2016
3Uric Acid (Urate)IBA
12/2020 - 05/2017
3MicroRNAs (MicroRNA)IBA
10/2020 - 01/2017
3Lipoproteins (Lipoprotein)IBA
12/2019 - 01/2019
3Ezetimibe (Zetia)FDA Link
01/2019 - 10/2017
3RivaroxabanIBA
01/2019 - 04/2016
3Troponin IIBA
02/2015 - 04/2007
3Brain Natriuretic Peptide (Natrecor)FDA Link
08/2013 - 12/2007
3AntithrombinsIBA
12/2005 - 12/2003
3TenecteplaseFDA Link
03/2005 - 04/2003
2Leuprolide (Lupron)FDA LinkGeneric
10/2021 - 03/2020
2acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamideFDA Link
10/2021 - 03/2020
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2021 - 03/2020
2CholesterolIBA
12/2020 - 11/2019
2ApolipoproteinsIBA
12/2020 - 11/2018
2HDL LipoproteinsIBA
12/2020 - 10/2008
2Glucose (Dextrose)FDA LinkGeneric
10/2020 - 01/2019
2AndrogensIBA
03/2020 - 01/2020
2Lipoprotein(a)IBA
01/2020 - 01/2020
2Cytochrome P-450 CYP2C19IBA
01/2019 - 03/2016

Therapy/Procedure

114Therapeutics
03/2021 - 01/2002
84Percutaneous Coronary Intervention
01/2020 - 12/2003
29Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2020 - 10/2005
11Secondary Prevention
02/2024 - 01/2012
11Stents
01/2020 - 12/2003
9Thrombolytic Therapy
12/2017 - 12/2003
7Drug-Eluting Stents
10/2016 - 09/2005
6Contraindications
10/2012 - 07/2005
5Length of Stay
11/2012 - 12/2005
4Blood Transfusion (Blood Transfusions)
10/2023 - 10/2005
4Erythrocyte Transfusion
05/2009 - 03/2005
3Patient Readmission
06/2015 - 04/2012